Concepedia

Paul F. McKay

PF

80

Publications

4.2K

Citations

34

H-Index

1998

Active since

Affiliations

Imperial College London(Current)

Beth Israel Deaconess Medical Center

St George's, University of London

Harvard University

University College London

Paul F. McKay is an author at Imperial College London specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

1998–2024

80

Publications

80

Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice

Paul F. McKay, Kai Hu, Anna K. Blakney et al. · Nature Communications · 2020 · 460 citations · Full text

Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA

Anna K. Blakney, Paul F. McKay, Bárbara Ibarzo Yus et al. · Gene Therapy · 2019 · 199 citations · Full text

, , +16

Identification of the 2B4 molecule as a counter-receptor for CD48.

Yvette Latchman, Paul F. McKay, Hans Reiser · PubMed · 1998 · 170 citations

, , +17

Big Is Beautiful: Enhanced saRNA Delivery and Immunogenicity by a Higher Molecular Weight, Bioreducible, Cationic Polymer

Anna K. Blakney, Yunqing Zhu, Paul F. McKay et al. · ACS Nano · 2020 · 150 citations · Full text

Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial

Katrina M. Pollock, Hannah M. Cheeseman, Alexander J. Szubert et al. · EClinicalMedicine · 2022 · 149 citations · Full text

Rows per page

1–5 of 80